Prometheus dissected: Will chaos rule in patenting?
This article was originally published in Scrip
Executive Summary
When the US Supreme Court invalidated diagnostic methods patents held by Prometheus Laboratories in a 20 March decision, John Whealan, associate dean for intellectual property law studies at George Washington Law School, said he found himself in the uncomfortable position of not being able to explain to his students why the justices ruled the way they did and what the decision meant.